KLK3 and cancer: The ongoing UK Prostate Testing for Cancer and Treatment Study (ProtecT) will randomize men with prostate cancer to receive radiation, undergo radical prostatectomy, or remain in observation; this trial is nested within a superior PSA screening trial, and study accrual is estimated to be completed in 2008.